Suppr超能文献

择期后路器械辅助脊柱融合手术患者的侵袭性感染:一项回顾性队列研究

Invasive Infection among Patients Undergoing Elective, Posterior, Instrumented Spinal Fusion Surgeries: A Retrospective Cohort Study.

作者信息

Begier Elizabeth, Rosenthal Ning A, Richardson William, Chung Jessica, Gurtman Alejandra

机构信息

Pfizer Inc., Pearl River, New York, USA.

Premier Applied Sciences, Premier Inc., Charlotte, North Carolina, USA.

出版信息

Surg Infect (Larchmt). 2022 Feb;23(1):12-21. doi: 10.1089/sur.2021.019. Epub 2021 Sep 7.

Abstract

Post-surgical invasive infections among spinal fusion patients are serious complications that can worsen clinical outcomes and increase healthcare utilization. Risk of such infections at the population level remains unknown. This study assessed the post-surgical risk of invasive infections among patients undergoing elective posterior instrumented spinal fusion surgeries in 129 U.S. hospitals. This retrospective cohort study analyzed adult patients ≥18 years of age who underwent thoracolumbar/lumbar and cervical fusion surgeries during 2010 - 2014 using the Premier Healthcare Database, the largest hospital discharge database in the United States. Risks of blood stream infection (BSI), deep or organ/space surgical site infections (SSI) caused by during 90 and 180 days post-index surgery were estimated. Infections were identified based on positive culture results, related (ICD-9) procedure codes, and specific claims information. Among 11,236 patients with thoracolumbar/lumbar fusion, 90- and 180-day BSI/SSI infection risks were higher for multilevel than single level fusion (90-day, 1.52% vs. 1.07%, p = 0.05; 180-day, 1.66% vs. 1.07%, p = 0.014). Among 1,641 patients with cervical fusion, 90- and 180-day BSI/SSI infection risks were also higher in multilevel fusions but not statistically significant (90-day, 1.66% vs. 0.52%, p = 0.350; 180-day, 1.80% vs. 0.51%, p = 0.241). The risk for SSI/BSI was more than twice as high among multilevel thoracolumbar/lumbar fusion patients with more than two comorbidities than those with no comorbidity at both 90-day (2.78% vs. 1.00%, p < 0.05) and 180-day (3.01% vs. 1.10%, p < 0.05). Similar trend without statistical significance was seen in multilevel cervical fusion cohort (90-day, 2.91% vs. 1.25%, p > 0.05; 180-day, 3.88% vs. 1.41%, p > 0.05). The risk of BSI/SSI infection for elective posterior instrumented spinal fusions ranged between 0.5% and 2%. Higher risk was observed in multilevel thoracolumbar/lumbar surgery, with infection risk greatest in patients with more than two comorbidities. These real-world findings highlight the need for additional measures, in addition to antibiotic prophylaxis, to reduce invasive infections in this setting.

摘要

脊柱融合手术患者术后发生侵袭性感染是严重的并发症,可使临床结局恶化并增加医疗资源的使用。此类感染在人群层面的风险仍不清楚。本研究评估了美国129家医院接受择期后路器械辅助脊柱融合手术患者术后发生侵袭性感染的风险。这项回顾性队列研究分析了2010 - 2014年期间使用美国最大的医院出院数据库——Premier医疗数据库,接受胸腰段/腰椎和颈椎融合手术的≥18岁成年患者。估计了索引手术后90天和180天内血流感染(BSI)、深部或器官/腔隙手术部位感染(SSI)的风险。根据阳性培养结果、相关的(ICD - 9)手术编码和特定的索赔信息来确定感染情况。在11236例接受胸腰段/腰椎融合手术的患者中,多节段融合患者90天和180天的BSI/SSI感染风险高于单节段融合患者(90天,分别为1.52%和1.07%,p = 0.05;180天,分别为1.66%和1.07%,p = 0.014)。在1641例接受颈椎融合手术患者中,多节段融合患者90天和180天的BSI/SSI感染风险也较高,但无统计学意义(90天,分别为1.66%和0.52%,p = 0.350;180天,分别为1.80%和0.51%,p = 0.241)。多节段胸腰段/腰椎融合且合并症超过两种的患者,其90天(2.78%对1.00%,p < 0.05)和180天(3.01%对1.10%,p < 0.05)的SSI/BSI感染风险是无合并症患者的两倍多。多节段颈椎融合队列中也观察到类似趋势,但无统计学意义(90天,分别为2.91%和1.25%,p > 0.05;180天,分别为3.88%和1.41%,p > 0.05)。择期后路器械辅助脊柱融合手术的BSI/SSI感染风险在0.5%至2%之间。多节段胸腰段/腰椎手术感染风险更高,合并症超过两种的患者感染风险最大。这些来自现实世界的研究结果凸显了除抗生素预防外,还需要采取额外措施来减少这种情况下的侵袭性感染。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验